Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 September 2018 Photo Anja Aucamp
Health forum celebrates 50 years of research
Throughout the years many renowned researchers shared their work via the Faculty Research Forum in the UFS Faculty of Health Sciences.

Fifty years ago, visionaries in healthcare established a research forum. Throughout the years, many renowned researchers shared their work via this platform. On 30 and 31 August 2018, the Faculty Research Forum in the Faculty of Health Sciences at the University of the Free State (UFS) hosted their annual event, and celebrated the forum’s 50th anniversary. The programme was characterised by high-quality presentations covering a range of relevant topics, with exhibitors displaying current and innovative technology in the health sciences field. 

On the shoulders of giants

According to the Faculty of Health Sciences Dean, Prof Gert van Zyl, the Faculty Research Forum is a highlight on their calendar. “We owe all our gratitude and appreciation to the founders of the forum, as well as 50 years of researchers who share their research with us each year.” This year was no exception, with interesting and relevant presentations. Evaluations committees comprising external and faculty adjudicators awarded prizes to research articles and student presentations. The level of work showcased once again proved that health science research on campus is alive and well – contributing to the study field. 

Small success

During the FP Retief Lecture, keynote speaker Prof Tahir Pillay shared his passion for new diagnostic probes for laboratory medicine using nanobodies and next generation technology. Prof Pillay is Chief Specialist, Professor and Head of the Department of Chemical Pathology at the University of Pretoria. He is also involved with the National Health Laboratory service, Steve Biko Academic Hospital and the Director of the Division of Clinical Pathology and Clinical Pathology training programme. 

A captive audience appreciated his explanation of what alpacas, llamas, and sharks have in common. These animals have small, single-chain, stable antibodies, significantly improving the possibilities in the field of antibody technology – a chance discovery with far-reaching impacts. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept